Lexicon Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LXRX and other ETFs, options, and stocks.About LXRX
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes.
CEOMichael Exton
CEOMichael Exton
Employees103
Employees103
HeadquartersThe Woodlands, Texas
HeadquartersThe Woodlands, Texas
Founded1995
Founded1995
Employees103
Employees103
LXRX Key Statistics
Market cap193.36M
Market cap193.36M
Price-Earnings ratio-1.03
Price-Earnings ratio-1.03
Dividend yield—
Dividend yield—
Average volume4.26M
Average volume4.26M
High today$0.62
High today$0.62
Low today$0.5311
Low today$0.5311
Open price$0.58
Open price$0.58
Volume6.13M
Volume6.13M
52 Week high$2.45
52 Week high$2.45
52 Week low$0.2836
52 Week low$0.2836
LXRX News
TipRanks 17h
Lexicon Pharmaceuticals: Strong Financials and Promising R&D Pipeline Justify Buy RatingIn a report released today, Joseph Pantginis from H.C. Wainwright maintained a Buy rating on Lexicon Pharmaceuticals (LXRX – Research Report), with a price targ...
People also own
Based on the portfolios of people who own LXRX. This list is generated using Robinhood data, and it’s not a recommendation.